Management strategies for posttransplant hypertension

Area of Science:

• Nephrology
• Cardiology
• Transplant Surgery

Background:

• Accelerated cardiovascular disease (CVD) remains a leading cause of premature death in transplant recipients.
• Arterial hypertension is a significant risk factor for CVD morbidity and mortality in the general population and a common post-transplant complication.

Purpose of the Study:

• To review the multifactorial pathogenesis of posttransplant hypertension (PTH) in renal transplant recipients.
• To emphasize the impact of immunosuppressive regimens on PTH development.
• To highlight the critical role of PTH in graft and patient survival and advocate for its strict management.

Main Methods:

• Review of existing literature on posttransplant hypertension.
• Analysis of contributing factors including recipient and donor history, graft function, and immunosuppressive medications.
• Synthesis of evidence supporting the need for aggressive treatment of PTH.

Main Results:

• PTH pathogenesis is multifactorial, involving recipient/donor hypertension, native kidney renin secretion, graft dysfunction, recurrent renal disease, and transplant artery stenosis.
• Calcineurin inhibitors and corticosteroids are key contributors to PTH across various transplant types.
• PTH is a major determinant of poor graft and patient survival.

Conclusions:

• Posttransplant hypertension is a critical, treatable complication impacting transplant outcomes.
• Management strategies for PTH should be as rigorous as those for essential hypertension, diabetes, or chronic kidney disease.
• Aggressive control of PTH is essential for improving long-term survival in transplant recipients.